The weight and wellness conversations that should be happening, written for everyone.
Anova translates the most credible voices in clinical science into clear, usable health information across the six areas that shape long-term wellbeing: medical, nutrition, movement, sleep, mental health, and the long arc of maintenance.
"Most health advice gets the headline right and the practice wrong."
At Anova
About Anova
If you've ever tried to make a sensible decision about your health and walked away more confused than when you started, this is for you. The information is out there, but it's contradictory, jargon-heavy, often selling something, and rarely written for the person actually living it. You shouldn't need a medical degree to know what to do next.
Anova exists to close that gap, for the people trying to look after themselves, and for the doctors trying to help them, across the six areas that shape long-term wellbeing: medical, nutrition, movement, sleep, mental health, and the long arc of maintenance.
You deserve the signal, not the noise
The science of health is full of confident voices saying different things. You shouldn't have to referee them. Anova draws from the most credible of them and works out what the evidence actually supports, so you're left with something clear enough to act on. It's the discipline behind everything we do, from the writing we publish today to the care we're building toward.
The whole picture, especially on weight
Weight is where health information goes quiet. Too often the medicine is prescribed, the side effects are listed once, and the rest is left to you to manage alone. Behavioural change gets a sentence when it needs a strategy. The science gets simplified into instructions instead of explained. Anova takes the opposite view: that you can handle the full picture, that the real-world challenges deserve real answers, and that people do better when they understand the why and have an experienced team alongside them while they work it out.
Within reach, whoever you are
Good health guidance shouldn't depend on what you earn, where you live, or who you know. Anova is built on data, analytics, and technology so that more people can reach trustworthy information more often, not fewer. Free where it can be, accessible by design.
What Matters
Long-term wellness sits across six interlocking areas. Our latest thinking on each is below.
Medical
How clinical interventions actually work, written clearly and reviewed carefully.
Nutrition
Protein, fibre, hydration, the rest. Practical, evidence-grounded, no fads.
Movement
Resistance training, Zone 2, walking: what actually changes outcomes long-term.
Sleep
Sleep is foundational and chronically under-discussed. We give it proper weight.
Mental health
Body image, motivation, the emotional arc of any health journey. Honest writing.
Long-term maintenance
The hardest, least-discussed phase of any health journey. We start here, not end here.
What we're thinking about
Sleep, from the basics up: what to fix first, and when to escalate
Most sleep advice arrives as a pile of tips with no order. The actual order: foundations first, then supplements, then medical treatment for sleep apnoea. Start at the bottom, escalate only when needed.
Eating well on a smaller appetite: flexibility, quality, and knowing your medication
A smaller appetite is not a smaller life. Two skills most people are never taught: eating for quality over quantity, and understanding your medication well enough to make flexible decisions with your prescriber.
What separates long-term success from regain: vigilant cognitive restraint, and the support that makes it possible
Long-term follow-up of people who have lost significant weight points to a single pattern in those who hold the loss: a sustained, flexible kind of attention that researchers call vigilant cognitive restraint.
Medication or surgery first? Making sense of the new weight management landscape
Why so many people reach for the injection before the operation, what the long-term evidence says, and how the two paths actually fit together.
Why two people on the same dose get different results: matching the medication to what drove the weight
Two people start the same medication at the same dose, and one loses a fifth of their body weight while the other barely shifts.
Your body changes faster than your self-image does
Many people who lose a significant amount of weight are surprised to find that the person in the mirror does not feel like them yet. The mind's picture of the body lags behind the body itself, sometimes by a long way.
Movement, for people who genuinely don't exercise
Most advice about exercise is written for people who already, on some level, exercise.
Life after the maintenance dose: do I have to stay on this forever?
The question almost everyone asks once the weight comes off is whether they have to stay on the medication for good.
The wonder drug is half a treatment: why the plan around it decides the outcome
For a lot of people, a GLP-1 medication feels like the last thing left to try after years of effort.
When the food noise goes quiet: the feeling no one warned you about
Many people on GLP-1 medications describe the constant hum of thoughts about food going silent. For most it is a relief. But for some the quiet spreads further. This is a name for that feeling, and what to do about it.
Eating well when you can't eat much: nutrition on weight management therapy
When appetite drops by a third on GLP-1 therapy, every bite has to do more work. Five nutritional priorities the 2025 joint advisory says the smaller plate needs to cover.
Nausea, bloating and burping on GLP-1s: one mechanism, three feelings, and what to do about each
Nausea, bloating and burping are the most common early side effects of GLP-1 medications. Why they happen, which ones to worry about, how they change over time, and the strategies that actually reduce them.
The wonder drug, I wonder
Almost weekly, a new claim. The major non-weight-loss GLP-1 claims graded from best evidenced to most speculative, the confident-but-wrong ones flagged, and the two most-discussed side effects put in their proper place.
Shift workers and weight: the hardest version of the problem
For shift workers, weight is harder to manage and rarely their fault. What circadian disruption does to the body, what is realistic when you can't fix the roster, and why this is a conversation a GP should start.
Delayed gastric emptying on GLP-1s: following the mechanism all the way through
Slowing the stomach is not a side effect of GLP-1 medications — it is the core mechanism. This piece follows it through to symptoms, upper-GI risks, procedural precautions, and the open long-term questions.
The sugar you cut, the sugar you didn't
Most Australians have cut obvious sugar and still consume 14 teaspoons daily. Most hides in food that doesn't taste sweet. Here's the mechanism, why exercise changes the picture, and where to look on the label.
The motivation you used to have: why exercise feels different on weight management therapy
Exercise motivation can quietly drop on weight management therapy. Not laziness: these medications act on reward pathways beyond appetite. Here's what the research shows and what it means for your training.
Fighting weight with one hand tied: the sleep question most patients never get asked
Sleep alone can contribute 4–8 kg of weight movement a year. Treating weight without addressing it is fighting with one hand behind your back. Here's the data, the mechanism, and why this lever is rarely discussed.
More than 1 in 5 men and young Australians don't see a GP. What that changes about care.
More than one in five Australian men don't see a GP in any given year. With no established GP relationship (or any particular desire for one), a telehealth avenue is a frictionless one.
The harder conversation: weight, antidepressants, and what we're actually asking medicine to fix
Roughly one in six Australian adults takes an antidepressant. Two in three live with overweight or obesity. The bind is real, the evidence is specific, and the clinical conversation most patients never get to have.
What no one tells you about constipation on GLP-1s, and what to do before you need to
Constipation is the most under-discussed common side effect of GLP-1 medications. Why the consult conversation skips it, why the standard advice often fails, and what to do before symptoms arrive.
What body composition actually does on GLP-1s, and what to do about it
The bathroom scale is the wrong instrument. So is the muscle-loss panic. The body composition story on GLP-1s is more nuanced and more reassuring than the public conversation suggests.
Pharmaceutical development is starting to move at consumer-technology speed
For three years, GLP-1 medications have looked like the ceiling of what medicine could do for weight management. The consensus was reasonable. It was also already wrong.
Why weight comes back when you stop the medication
The story most people are told: take the medication, lose the weight, come off it, keep the result. It sounds reasonable. It's also wrong, and understanding why matters before you start.
What changed: the modern environment and your body
The body walking into a 2026 appointment is biologically the same as in 1975. The environment around it is not. The honest weight conversation starts with what changed, not with the person.
Popular but wrong: "just eat less and move more"
The most-repeated piece of weight advice in English is technically correct and practically misleading. The body actively defends its weight. Here's what the science says instead.
Top 5 things diet, exercise, sleep, and stress actually do for weight
The standard advice treats diet, exercise, sleep, and stress as roughly equal levers. The evidence says they aren't. Knowing what each lever actually delivers makes the conversation honest.
What the system gets wrong about weight
Two-thirds of Australian adults live with overweight or obesity. The standard advice has not worked. The failing isn't yours; it's structural. The science has moved on, the clinical conversation hasn't.
Good care doesn't run around your GP. It runs with them.
Anova is built around a simple proposition: the patient's GP stays at the centre of their care. Around that GP sits a specialist medical lead governing the program, allied health where appropriate, and the platform tools that let everyone share what matters. We're not building a parallel prescriber. We're building the connective tissue good care has always needed.
A specialist sets the standard the network runs on.
In a well-designed Care Network, weight management isn't a generic prescribing pathway; it's a clinical program governed by a specialist with deep expertise in the area. The specialist sets the protocols, owns the escalation rules, and is accountable for the standard the whole network operates to. The GP refers in confidently because they know who's holding the line.
The patient's GP can see what's happening, because they're part of it.
In a Care Network, the GP isn't notified after the fact; they're part of the relationship from the start. They see what the patient is on, what changed, what the specialist saw, and what's coming next. Continuity of care isn't a marketing claim; it's whether the GP could pick up the phone tomorrow and know exactly where their patient stands.
A real consultation, before a real prescription.
Pre-consult intake does two jobs. Clinically, it captures the history a clinician needs (efficiently, in the patient's own time, with the depth a 15-minute consult can't). Humanly, it's the first place the patient feels seen: questions that recognise not every diet works for every body, that life context shapes what's possible, that previous attempts aren't failures. The consultation is where it all gets validated: a registered Australian clinician on video or phone, in real time, asking what the form couldn't and confirming what it did. The intake makes the conversation better; the conversation is what makes the prescription safe.
Weight management research today is mostly academic, and academia can only see so much.
Most of what we know about GLP-1s comes from twelve-month industry trials with controlled cohorts. What happens at month eighteen, at maintenance, at deprescribing, in real patients with real lives: that data largely sits unstructured inside specialty practices. The research opportunity is the other way around: a specialty practice with the right data infrastructure, working with academic researchers who can examine it, can answer questions trials weren't designed to ask. A Care Network worth referring to is one being built with that loop in mind from day one.
A note on the patients these networks miss.
Even a well-built Care Network leaves a hard question open: what about the patients who never enter through it? Some haven't raised weight with their GP because of shame. Some have, and the practice didn't offer structured weight management. Some have moved cities, lost continuity, or never had it. And some, for reasons of their own, don't want their GP involved.
The honest answer is that the model doesn't yet exist that handles all of these well. Most of the questions are still open. Should the program offer a bridge back to primary care (a referral letter the patient can take to a GP of their choosing, an introduction service, a structured pathway to bring their GP in later)? Where the patient declines that bridge, what does responsible care look like: closer monitoring, clearer escalation thresholds, an open door to revisit at any point?
These aren't questions a script-driven model has to ask. They're questions a Care Network has to. We don't think the answers are obvious yet. We do think they're the questions worth working on.
The next step, when you're ready for one.
Understanding is where good health decisions start. For some, the next step is working with a clinical team that holds the same standard, the one behind everything on this site. Anova's clinical program is built on the principles you'll find across this site: specialist-governed, GP co-care, evidence-based, designed for the long arc rather than the quick result.
Anova is in pre-launch. Our founding-member clinical program opens in 2026. Roles are available in medical governance and clinical leadership, providing input into governance, protocols, and platform capabilities.
Speak with our teamEditorial credibility you can see.